Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

NCT06203821 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: NP137

Sponsor

Aram Hezel

Collaborators

[object Object]